TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 35 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | -81.8% | 10,000 | 0.0% | 0.00% | -75.0% |
| Q2 2018 | $11,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | -15.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $13,000 | -27.8% | 10,000 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $18,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 10,000 | $13,000 | 0.01% |
| Stone Ridge Asset Management LLC | 30,698 | $41,000 | 0.00% |
| WEDBUSH SECURITIES INC | 13,500 | $18,000 | 0.00% |
| Westside Investment Management, Inc. | 2,889 | $4,040,000 | 0.00% |
| Wealthspire Advisors, L.P. | 11,708 | $16,000 | 0.00% |
| Blume Capital Management, Inc. | 2,546 | $3,000 | 0.00% |
| American Portfolios Advisors | 2,729 | $3,616 | 0.00% |
| Renaissance Technologies | 552,200 | $732,000 | 0.00% |
| ROYAL BANK OF CANADA | 18 | $0 | 0.00% |
| UBS Group AG | 237 | $0 | 0.00% |